<SEC-DOCUMENT>0001387131-16-005907-index.html : 20160627 <SEC-HEADER>0001387131-16-005907.hdr.sgml : 20160627 <ACCEPTANCE-DATETIME>20160627165305 ACCESSION NUMBER: 0001387131-16-005907 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20160411 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160627 DATE AS OF CHANGE: 20160627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 161733862 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>admp-8k_041116.htm <DESCRIPTION>AMENDED CURRENT REPORT <TEXT> Document 1 - file: admp-8k_041116.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>2 <FILENAME>ex23-1.htm <DESCRIPTION>CONSENT OF PUBLIC ACCOUNTING FIRM <TEXT> Document 2 - file: ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>ex99-1.htm <DESCRIPTION>FINANCIAL STATEMENTS LISTED IN ITEM 9.01(A) <TEXT> Document 3 - file: ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>4 <FILENAME>ex99-2.htm <DESCRIPTION>PRO FORMA FINANCIAL INFORMATION LISTED IN ITEM 9.01(B) <TEXT> Document 4 - file: ex99-2.htm
</DOCUMENT> </SEC-DOCUMENT>